Member Exclusive

Inhalable ibuprofen may be the future of cystic fibrosis treatment

Researchers from the Texas A&M Health Science Center College of Medicine (Round Rock, TX, USA) are developing an inhalable form of ibuprofen, which could be used to treat cystic fibrosis patients without the negative side effects associated with high doses of ibuprofen.

Go to the profile of Stella Bennett
Jul 06, 2016

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.